Researchers have modified transcranial magnetic stimulation (TMS), significantly improving its effectiveness in treating hard-to-treat depression. In a recent study, this novel TMS protocol achieved a 66% response rate and 42% acute remission in patients with major depressive disorder, surpassing the standard FDA-approved protocol's 29% response rate.
